Furthermore, the role of IL-34 in tumours is controversial particularly in the development, metastasis and prognosis of cancers, although the response to MCSF is tumour-type dependant, possibly due to the levels of M-CSF receptors [18]. The gene discussed is IL34; the disease is cancer.